Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Citius Pharmaceuticals Inc
47NCurrent price
0.41 EUR
-0.000000000019 EUR (0.00%)
Last closed
0.48 USD
Company
www.citiuspharma.com
ISIN
US17322U2078
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
74 368 336 USD
Yield for 12 month
-50.11 %
1Y
3Y
5Y
10Y
15Y
47N
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Its late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. The company was founded in 2007 and is headquartered in Cranford, New Jersey. Address: 11 Commerce Drive, Cranford, NJ, United States, 07016
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-194 316 USD
Last Year
-179 677 USD
Current Quarter
-52 848 USD
Last Quarter
-52 070 USD
Key Figures 47N
1 year
3 years
5 years
10 years
EBITDA
-41 067 916 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.74 %
PEG Ratio
–
Return On Equity TTM
-41.49 %
Wall Street Target Price
4.67 USD
Revenue TTM
–
Book Value
0.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.24 USD
Diluted Eps TTM
-0.24 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 47N
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 47N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
09.06.2017
Dividend Date
09.06.2017
Stock Valuation 47N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
7.4794
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.7425
Price Book MRQ
0.8679
Financials 47N
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 47N
For 52 weeks
0.31 USD
1.07 USD
50 Day MA
0.45 USD
Shares Short Prior Month
12 768 363
200 Day MA
0.66 USD
Short Ratio
10.99
Shares Short
12 421 963
Short Percent
7.38 %
BeatStart